SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-060006
Filing Date
2018-11-14
Accepted
2018-11-14 16:50:37
Documents
42
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv506527_10q.htm 10-Q 493759
2 EXHIBIT 31.1 tv506527_ex31-1.htm EX-31.1 9931
3 EXHIBIT 31.2 tv506527_ex31-2.htm EX-31.2 9866
4 EXHIBIT 32.1 tv506527_ex32-1.htm EX-32.1 3676
5 EXHIBIT 32.2 tv506527_ex32-2.htm EX-32.2 3581
  Complete submission text file 0001144204-18-060006.txt   2667850

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atxi-20180930.xml EX-101.INS 580577
7 XBRL TAXONOMY EXTENSION SCHEMA atxi-20180930.xsd EX-101.SCH 23343
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20180930_cal.xml EX-101.CAL 21645
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20180930_def.xml EX-101.DEF 156956
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20180930_lab.xml EX-101.LAB 170369
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20180930_pre.xml EX-101.PRE 176279
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 181184763
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1